We have noted that US health care has been taken over by generic managers . A recent article about the CEOs of purportedly some of America...
Read More
07.54
Add Comment
CHF,
clinical trials,
Entresto,
evidence-based medicine,
manipulating clinical research,
Novartis,
sacubitril
Edit
Entresto: Blockbuster, or Just Over Hyped? - Whatever, It Will Cost $4500 a Year
The newest drug for congestive heart failure, Entresto, a fixed combination of valsartan and sacubitril, has just hit the market at an eleva...
Read More
What They Really Think of Us, UK Version - Health Secretary Derides NHS Doctors for Not Working Enough on Weekends
A new story from the UK suggests what top leaders of health care really think about health care professionals. I realize that I risk showin...
Read More
New arrivals from Anchorage Brewing, Grimms, and some key restocks!
The Lost Abbey Framboise de Amorosa Lost Abbey takes their Lost & Found Belgian-style ale and ages it in oak over multiple additions of ...
Read More
12.51
Add Comment
AHIP,
Centers for Medicare and Medicaid Services,
CMS,
HCA,
Medicare,
revolving doors
Edit
Turn, Turn, Turn - from Columbia/ HCA Executive, to Virginia Secretary of Health and Human Resources, to Director of the Center for Medicare and Medicaid Services (CMS), to America's Healt Insurance Plans (AHIP)
Marilyn Tavenner's career continues to revolve, er, evolve. Columbia/ HCA Marilyn Tavenner worked for Columbia / HCA, now HCA, although ...
Read More
HOTTER than July! Err...
NEW ARRIVALS for this week at BOTH stores: Cascade Strawberry 2014 Project! A wheat ale aged over whole strawberries and vanilla beans in oa...
Read More
18.29
Add Comment
boards of directors,
conflicts of interest,
executive compensation,
mission-hostile management,
Mylan,
perverse incentives
Edit
Who Benefits? - Rising Generic Drug Prices and the Case of Mylan's Conflicted Property Purchases
Rising Generic Drug Prices Health care costs in the US continue their seemingly inexorable rise. Even the parts of health care that used to...
Read More
Bill Clinton, Paid to Speak to Biotech Conference, Extolled $1000 Pill to Prevent "Liver Rot," Despite Lack of Evidence that It Does
What were they thinking? Former President Clinton Talkes to Pharma and Biotech Executives In mid June, 2015, the Philadelphia Inquirer repor...
Read More
Langganan:
Postingan (Atom)